Michael Neuberger Obituary | Science | Theguardian.Com
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Professor Michael Neuberger: Biochemist Behind Life-Saving
Professor Michael Neuberger: Biochemist behind life-saving ... http://www.independent.co.uk/news/obituaries/professor-mich... THE INDEPENDENT FRIDAY 08 NOVEMBER 2013 NEWS VOICES SPORT TECH LIFE PROPERTY ARTS + ENTS TRAVEL MONEY INDYBEST BLOGS UK World Business People Science Environment Media Technology Education Obituaries Diary 1 of 15 08/11/2013 10:36 Professor Michael Neuberger: Biochemist behind life-saving ... http://www.independent.co.uk/news/obituaries/professor-mich... News > Obituaries Professor Michael Neuberger: Biochemist behind life-saving work on the immune system He was seen as an outstanding mentor, with his sharp intellect and ability to get to the core issue Friday 01 November 2013 Shares: 28 PRINT A A A FOOD+DRINK Professor Michael Neuberger was pivotal to the ADS BY GOOGLE great advances in biomedical research, with his You Could Be Owed unravelling of the mysteries of human £2400 If You've Ever Had A Loan antibodies. A Fellow of Trinity College, You Could Be Owed A Cambridge where he was a director of studies in Refund Natural Sciences, he was also deputy director of LloydsTSB.BankRefunds.ne t Cambridge’s Medical Research Council FreeWatt Solar PV Laboratory of Molecular Biology (LMB). Biomass Lincs Renewable Energy With the demand for a new class of drugs to Matcha the day: Company of 2012. Heard about the fight diseases, such as cancer, as well as immune Commercial & Domestic soft drink set to be Systems disorders such as rheumatoid arthritis, the the next big thing? www.freewatt.co.uk bio-tech industries have shown rapid growth. Buddhist monks Top10 Broadband in the Over 25 years, Neuberger made significant certainly have – they've UK been enjoying this Broadband From £2.50. -
Fellowship, to the Crown
2013 TRINITY COLLEGE cambridge trinity college cambridge annual record annual record 2013 Trinity College Cambridge Annual Record 2012–2013 Trinity College Cambridge CB2 1TQ Telephone: 01223 338400 e-mail: [email protected] website: www.trin.cam.ac.uk Cover photo: Aldous Bertram Contents 5 Editorial 9 The Master’s Installation Dinner 10 Speech of Welcome by Professor David McKitterick 13 Reply by Sir Gregory Winter 17 Commemoration 18 Chapel Address 22 The Health of the College 24 The Master’s Response on behalf of the College 29 Alumni Relations and Development 30 The Office and the Annual Fund 32 Alumni Associations 42 Annual Gatherings C 43 Alumni Achievements ontent 47 Benefactions 65 College Activities S 67 First & Third Trinity Boat Club 71 Field Club 88 Students’ Union and Societies 107 College Choir 109 Features 110 Heading South: Michael Proctor 112 Magnificent Seven: Trinity Men and Mrs Thatcher 118 Building the Bouncing Bomb: the Dambusters Raid seventy years on TRINITY ANNUAL RECORD 2013 3 131 Fellows, Staff and Students 132 The Master and Fellows 144 Appointments and Distinctions 149 In Memoriam 158 College Notes 167 The Register 168 In Memoriam 172 Addresses Wanted 191 An Invitation to Donate S content TRINITY ANNUAL RECORD 2013 | 4 Editorial The first highlight of the year occurred as early as 2 October when Sir Gregory Winter was installed as Master, just in time for a photograph of the ceremony to appear in our last edition. There were no speeches on that occasion, but on 30 November a special dinner was held, in lieu of the Audit Feast, to celebrate the Master’s installation. -
Outputs, Outcomes and Impact of MRC Research: 2012 Report 10: Impacts on the Private Sector 10: Impacts on the Private Sector
Outputs, outcomes and impact of MRC research: 2012 report 10: Impacts on the private sector 10: Impacts on the private sector Impacts on the private sector Summary The MRC is interested in the contribution that its research has made to the formation and growth of spin out companies. It is hoped that MRC research will lead to discoveries that can be commercially exploited and result in positive economic impacts such as employment, provision of new goods and services, and direct investment into the UK. The formation of spin out companies is one route to this. It is important that the MRC can both describe its contribution in this area and understand better the processes leading to the successful formation of spin out companies. The MRC is not suggesting that the setting up of spin out companies per se is a measure of success. We are interested in the downstream impact realised, as a result of pursuing this route to commercialisation. The MRC has had a spectacular track record in this area. Cambridge Antibody Technology (CAT), formed in 1989, is still noted as the only academic spin out which has resulted in the discovery of a blockbuster treatment (Humira). CAT was acquired by AstraZeneca in 2006 for £702 million, at which time CAT employed more than 300 staff. An earlier route to commercialising MRC research was the formation of Celltech by the National Enterprise Board in 1980, which floated on the stock exchange in 1993 and was bought by the Belgian Pharmaceutical company UCB in 2004 for £1.53 billion. At that time, Celltech employed around 1,900 people, 450 of which worked in research and development. -
A Tribute to Michael S. Neuberger
A tribute to Michael S. Neuberger Patricia J. Gearhart, Garnett Kelsoe J Clin Invest. 2014;124(1):3-5. https://doi.org/10.1172/JCI74366. Obituary Michael S. Neuberger, whose contributions to the field of molecular biology of B lymphocytes paved the way for humanizing therapeutic antibodies and understanding the genetic mechanisms of antibody expression, affinity maturation, and class switching, died October 26th, 2013, of multiple myeloma, at the age of 59 (Figure 1). Michael Neuberger was the youngest of four sons of the distinguished biochemist, Albert Neuberger, and his artist wife, Lilian. Albert Neuberger left Germany in 1933, as the Nazis came to power, and settled in London where he became a professor of chemical pathology. Remarkably, Fred Sanger, Albert Neuberger’s distinguished student, was the mentor of Cesar Milstein, who in turn, started Michael Neuberger along his own career. Neuberger studied biochemistry at the University of Cambridge and began his scientific career with Brian Hartley at Imperial College London, working on the evolution of enzymes in bacteria. His doctoral work earned him a research fellowship from Trinity College, Cambridge, where he sought out Milstein’s help to enter the new field of molecular immunology. Milstein offered him a position in the Medical Research Council Laboratory of Molecular Biology (LMB) but sent him first to the laboratory of Klaus Rajewsky in Cologne to “learn immunology.” After working in Germany for two years on immunoglobulin class-switched antibody pairs, Neuberger returned to the LMB where he began to study […] Find the latest version: https://jci.me/74366/pdf Obituary A tribute to Michael S.